Previously, it was recognized that IGF-II/IGFBP2 complex may partly bind to the extracellular matrix (ECM) from where IGF-II may be liberated by proteolysis [28], suggesting the role of IGFBP2 as a storage pool for IGF-II in the tumor microenvironment [17]. The gene discussed is IGF2; the disease is neoplasm.